Mental health disorders are costly
Mental health disorders, such as major depressive disorder are known to worsen symptoms of existing chronic conditions, leading to functional decline, disability, and loss of quality of life. Mental health comorbidities lead to excessive treatment and worsened overall health outcomes.
Existing screening and managing tools for mental health conditions are very limited. As a result, majority of individuals affected by mental health conditions do not receive adequate care.
At Ensofy we are building novel vocal biomarkers technology that allows instant and non-invasive management of mental health disorders. We partner with care providers internationally to address the colossal unmet need in mental health care.
Underserved
Mental health disorders are under-diagnosed and under-treated. In the US, up to 60% of those affected never receive any care.
Underreported
Existing screening tools for mental health are largely limited.
As a result, only 1 in 5 GPs records the mental health state of their patients.
Up to 6.2x Excess Costs
Mental health comorbidities lead to lengthy hospitalizations, unnecessary complications and excessive healthcare costs.
Human Voice is a Window into the Human Mind.
As early as 1927, clinical psychiatrists noted the distinct vocal pattern that depressed individuals have. Today we know that people experiencing mental health disorders, such as depression undergo specific neurophysiological and cognitive changes that directly affect their vocal profile.
At Ensofy, we are building an AI/ML solution, called VoiceAI, that identifies the changes in the voice to non-invasively detect mental health conditions. VoiceAI helps caretakers easily manage the mental health of their patients as it requires only 30 seconds of free-form speech.
